Hochschulschrift
A two-chain chimeric antigen receptor (CAR) scaffold recruits endogenous CD3 for superior T-cell function
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
113 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Literaturverzeichnis Seite 101-108
Enthält deutsche und englische Zusammenfassung
Im Titel ist "3" tiefgestellt
Johannes Gutenberg-Universität Mainz, Dissertation, 2019
- Event
-
Veröffentlichung
- (where)
-
Mainz
- (when)
-
[2019]
- Creator
- Contributor
-
Johannes Gutenberg-Universität Mainz
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:15 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Birtel, Matthias
- Johannes Gutenberg-Universität Mainz
Time of origin
- [2019]
Other Objects (12)
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry-species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry species conversion in CD3 systems
Optimization of chimeric antigen receptor (CAR) therapy
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry-species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry species conversion in CD3 systems
Optimization of chimeric antigen receptor (CAR) therapy
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
Approaches to improve outcome of hepatitis B virus-specific chimeric antigen receptor T-cell therapy
Two cases of pancytopenia with Coombs-negative hemolytic anemia after chimeric antigen receptor T-cell therapy
Evolutionary engineering of a cp*rh(iii) complex-linked artificial metalloenzyme with a chimeric β-barrel protein scaffold
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Adoptive T-cell Therapy via Chimeric Antigen Receptors (CARs) against Leukemia in Combination with a human Suicide Gene
Targeting AML using a CD33/CD3 T-cell recruiting antibody : studying mode of action and evolving resistance mechanisms
T-cell surveillance of therapy-induced senescent lymphoma cells in the presence of anti-CD19/CD20 × CD3 bispecific antibodies
Symmetry-species conversion in CD3 systems
Optimierung eines bispezifischen FLT3xCD3 Antikörpers
Symmetry species conversion in CD3 systems